Northstar products Snorenz and Stem-Intense generate overwhelming orders in just the first few days of online sales

HOLBROOK, N.Y., Jan. 24, 2013 /PRNewswire/ -- Northstar Global Business Services, Inc. Symbol (OTCPink: MDIN), today announced that its online store, launched just one week ago, is generating a tremendous number of orders. On Friday January 18th, two of Northstar's products, Snorenz and Stem-intense became available for purchase from it's website at www.medgeninc.com. The company is proud to say that the orders started to flow almost instantaneously causing a tidal wave of sales.

In preparation for the launch, the company stockpiled what they assumed would be a sixty day supply of both products for fulfillment of online orders, but after just five days the company has been forced to order several times that amount to keep up with the unexpected demand. Northstar's CEO, Nick Chieco commented, "The last thing I wanted was for people to be forced to wait unreasonable amounts of time to receive our products, but it is a clear indicator of just how successful these products will be."  One of the products, Snorenz, is a patented anti-snoring spray, which has been a very popular seller ever since its inception over ten years ago, but was was taken off the shelves from 2009 until its re-launch earlier this year. The second, Stem-Intense, is a new and unique, patent pending product that uses leading edge stem cell replacement therapy to help fitness buffs and workout fanatics pack on muscle mass many times the normal rate. Both appear to have a very large following online.

According to Mr. Chieco, "the reason the company made these products available earlier than planned was that due to the slow retail roll-out times the company is experiencing as a result, in part, of the super storm that ravaged the east coast earlier in the year. Because of the storm, as well as several other factors beyond Northstar's control, most major retailers are taking longer than usual to get new products on shelves. We planned to be on most shelves nationwide by now but instead have only seen sporadic distribution as of yet because of the impact these factors have had."

Even though Northstar's products are shipping as planned, the length of time it takes to get those products on store shelves for the first time in years is in the hands of the retailers. Stores like Wal-mart, Target, Walgreens, and other large chains have experienced a negative impact on sales and many other aspects of their business following the storm. That impact has an effect on everyone.

On January 23rd, Mr. Cheico emailed each and every customer to notify them of a slight delay and assure them that their purchase will be on its way shortly. After the initial surge, which averaged about 100 orders every few minutes, sales leveled out to a reasonable but still amazing number and seem to be holding at a steady pace. The company plans to wait until the current orders are all shipped and new orders come down to around 300 per day before a complete overhaul of the website design, and the launch of massive pay-per-click, and print marketing campaigns aimed at multiplying that number by a factor of ten. The average order is currently around $42.00 USD. After all is said and done the company feels that while brick and mortar retail is necessary to maintain credibility and gain consumer confidence and exposure, direct online sales may turn out to generate three or four times as much net profit for the company. Anyone interested in purchasing Northstar's products are encouraged to visit the company's website at www.medgeninc.com.

For more information about Northstar, Contact Jennifer at 1-877-571-4387 or Email: investors@northstarbb.com

About Northstar

Northstar Global Business Services is dedicated to producing the best alternative healthcare products. The most popular products in Northstar's arsenal are Snorenz[R], a patented spray for snoring relief and "Good Night's Sleep[R]", an FDA approved sleep aid. Most of the company's products use a unique spray delivery system, and have received very positive consumer reviews all over the world, selling millions upon millions of units from 1996 to the present.

DISCLAIMER

This Press Release may contain certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company has tried, whenever possible, to identify these forward-looking statements using words such as "anticipates," "believes," "estimates," "expects," "plans," "intends," "potential" and similar expressions. These statements reflect the Company's current beliefs and are based upon information currently available to it. Accordingly, such forward-looking statements involve known and unknown risks, uncertainties and other factors which could cause the Company's actual results, performance or achievements to differ materially from those expressed in or implied by such statements. The Company undertakes no obligation to update or advise in the event of any change, addition or alteration to the information catered in this Press Release including such forward-looking statements.

SOURCE Northstar Global Business Services, Inc.

Copyright 2013 PR Newswire

MedGen (CE) (USOTC:MDIN)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024 Click aqui para mais gráficos MedGen (CE).
MedGen (CE) (USOTC:MDIN)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024 Click aqui para mais gráficos MedGen (CE).